Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2022

Open Access 01-12-2022 | Craniopharyngioma | Research

Coexistence of craniopharyngioma and cranial fibrous dysplasia: a case series of clinicopathological study

Authors: Yang-Hua Fan, Zhi Li

Published in: Orphanet Journal of Rare Diseases | Issue 1/2022

Login to get access

Abstract

Background

Craniopharyngioma (CP) and cranial fibrous dysplasia (CFD) are rare embryonic benign cranial diseases that most commonly present during childhood or adolescence. The coexistence of CP and CFD is extremely rare and has not yet been reported.

Methods

We retrospectively reviewed the data of five patients with concomitant CP and CFD treated at Beijing Tiantan Hospital from January 2003 to January 2021 and summarized their clinicopathological features, treatment modalities, and outcomes. We also performed a comprehensive literature review, tested the patients for characteristic GNAS gene mutations related to CFD, and tested the CP specimens for corresponding Gsα protein to explore the potential connection leading to the coexistence of CP and CFD.

Results

The cohort comprised four men and one woman (median age, 39 years). The symptoms mainly included headache, dizziness, fatigue, polyuria/polydipsia, hypogonadism, and blurred vision. CFD most commonly involved the sphenoid bone (n = 4). Four patients underwent surgery to remove the CP (one trans-sphenoidal and three transcranial resections); complete and subtotal resection were achieved in two patients, respectively. The tumor subtype was adamantinomatous in three patients and unknown in one. The common postoperative complications were panhypopituitarism, diabetes insipidus, and hypothyroidism. The mean follow-up duration was 57.2 months. Two patients required postoperative hormone replacement therapy. Three patients underwent genetic study of the tumor specimens; GNAS mutations were not detected, but these patients were positive for Gsα protein.

Conclusions

Although a definite causative relationship has not been proved, the coexistence of CP and CFD means that potential interplay or an atypical fibrous dysplasia course as uncommon manifestations of CP cannot be excluded. It is more challenging to initiate prompt diagnosis and appropriate treatment for concomitant CP and CFD than for solitary CP because of skull base deformations. Current management strategies are aimed at surgical treating the CP and regularly monitoring the CFD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Martinez-Barbera JP, Andoniadou CL. Biological behaviour of craniopharyngiomas. Neuroendocrinology. 2020;110(9–10):797–804.CrossRef Martinez-Barbera JP, Andoniadou CL. Biological behaviour of craniopharyngiomas. Neuroendocrinology. 2020;110(9–10):797–804.CrossRef
2.
go back to reference Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89(4):547–51.CrossRef Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89(4):547–51.CrossRef
3.
go back to reference Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol. 2002;161(6):1997–2001.CrossRef Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol. 2002;161(6):1997–2001.CrossRef
4.
go back to reference Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER Jr, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161–5.CrossRef Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER Jr, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161–5.CrossRef
5.
go back to reference Weinstein LS. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome. J Bone Miner Res. 2006;21(Suppl 2):P120–4.CrossRef Weinstein LS. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome. J Bone Miner Res. 2006;21(Suppl 2):P120–4.CrossRef
6.
go back to reference Diah E, Morris DE, Lo LJ, Chen YR. Cyst degeneration in craniofacial fibrous dysplasia: clinical presentation and management. J Neurosurg. 2007;107(3):504–8.CrossRef Diah E, Morris DE, Lo LJ, Chen YR. Cyst degeneration in craniofacial fibrous dysplasia: clinical presentation and management. J Neurosurg. 2007;107(3):504–8.CrossRef
7.
go back to reference Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, Bianco P. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol. 1999;187(2):249–58.CrossRef Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, Bianco P. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol. 1999;187(2):249–58.CrossRef
8.
go back to reference Tafti D, Cecava ND, Fibrous Dysplasia, StatPearls, Treasure Island (FL), 2021. Tafti D, Cecava ND, Fibrous Dysplasia, StatPearls, Treasure Island (FL), 2021.
9.
go back to reference Maiuri F, Cappabianca P, Iaconetta G, Esposito F, Messina A. Simultaneous presentation of meningiomas with other intracranial tumours. Br J Neurosurg. 2005;19(4):368–75.CrossRef Maiuri F, Cappabianca P, Iaconetta G, Esposito F, Messina A. Simultaneous presentation of meningiomas with other intracranial tumours. Br J Neurosurg. 2005;19(4):368–75.CrossRef
10.
go back to reference Singh DK, Singh N, Parihar A, Singh R. Craniopharyngioma and epidermoid tumour in same child: a rare association, BMJ Case Rep 2013 (2013). Singh DK, Singh N, Parihar A, Singh R. Craniopharyngioma and epidermoid tumour in same child: a rare association, BMJ Case Rep 2013 (2013).
11.
go back to reference Takei H, Powell SZ. Tumor-to-tumor metastasis to the central nervous system. Neuropathology. 2009;29(3):303–8.CrossRef Takei H, Powell SZ. Tumor-to-tumor metastasis to the central nervous system. Neuropathology. 2009;29(3):303–8.CrossRef
12.
go back to reference Amit A, Achawal S, Dorward N. Pituitary macro adenoma and vestibular schwannoma: a case report of dual intracranial pathologies. Br J Neurosurg. 2008;22(5):695–6.CrossRef Amit A, Achawal S, Dorward N. Pituitary macro adenoma and vestibular schwannoma: a case report of dual intracranial pathologies. Br J Neurosurg. 2008;22(5):695–6.CrossRef
13.
go back to reference Hasegawa H, Jentoft ME, Young WF Jr, Lakomkin N, Van Gompel JJ, Link MJ, Atkinson JL, Meyer FB. Collision of Craniopharyngioma and pituitary adenoma: comprehensive review of an extremely rare Sellar condition. World Neurosurg. 2021;149:e51–62.CrossRef Hasegawa H, Jentoft ME, Young WF Jr, Lakomkin N, Van Gompel JJ, Link MJ, Atkinson JL, Meyer FB. Collision of Craniopharyngioma and pituitary adenoma: comprehensive review of an extremely rare Sellar condition. World Neurosurg. 2021;149:e51–62.CrossRef
14.
go back to reference Liu G, Su L, Xiang Y, Liu Y, Zhang S. Coexistence of craniopharyngioma and meningioma: two rare cases and literature review. Medicine (Baltimore). 2020;99(50):e23183.CrossRef Liu G, Su L, Xiang Y, Liu Y, Zhang S. Coexistence of craniopharyngioma and meningioma: two rare cases and literature review. Medicine (Baltimore). 2020;99(50):e23183.CrossRef
15.
go back to reference Pekmezci M, Louie J, Gupta N, Bloomer MM, Tihan T. Clinicopathological characteristics of adamantinomatous and papillary craniopharyngiomas: University of California, San Francisco experience 1985–2005. Neurosurgery. 2010;67(5):1341–9 (discussion 1349).CrossRef Pekmezci M, Louie J, Gupta N, Bloomer MM, Tihan T. Clinicopathological characteristics of adamantinomatous and papillary craniopharyngiomas: University of California, San Francisco experience 1985–2005. Neurosurgery. 2010;67(5):1341–9 (discussion 1349).CrossRef
16.
go back to reference Ghosal N, Furtado SV, Santosh V, Sridhar M, Hegde AS. Co-existing fibrous dysplasia and atypical lymphoplasmacyte-rich meningioma. Neuropathology. 2007;27(3):269–72.CrossRef Ghosal N, Furtado SV, Santosh V, Sridhar M, Hegde AS. Co-existing fibrous dysplasia and atypical lymphoplasmacyte-rich meningioma. Neuropathology. 2007;27(3):269–72.CrossRef
17.
go back to reference Tasar M, Ors F, Yetiser S, Ugurel MS, Ucoz T. Multiple globoid meningiomas associated with craniomandibular fibrous dysplasia: case report. Clin Imaging. 2004;28(1):20–2.CrossRef Tasar M, Ors F, Yetiser S, Ugurel MS, Ucoz T. Multiple globoid meningiomas associated with craniomandibular fibrous dysplasia: case report. Clin Imaging. 2004;28(1):20–2.CrossRef
18.
go back to reference Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, Van Wyk JJ, Merino MJ, Feuillan PP, Spiegel AM. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr. 1993;123(4):509–18.CrossRef Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, Van Wyk JJ, Merino MJ, Feuillan PP, Spiegel AM. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr. 1993;123(4):509–18.CrossRef
19.
go back to reference Spencer T, Pan KS, Collins MT, Boyce AM. The Clinical SPECTRUM of McCune–Albright syndrome and its management. Horm Res Paediatr. 2019;92(6):347–56.CrossRef Spencer T, Pan KS, Collins MT, Boyce AM. The Clinical SPECTRUM of McCune–Albright syndrome and its management. Horm Res Paediatr. 2019;92(6):347–56.CrossRef
20.
go back to reference Robinson C, Estrada A, Zaheer A, Singh VK, Wolfgang CL, Goggins MG, Hruban RH, Wood LD, Noe M, Montgomery EA, Guthrie LC, Lennon AM, Boyce AM, Collins MT. Clinical and radiographic gastrointestinal abnormalities in McCune-Albright syndrome. J Clin Endocrinol Metab. 2018;103(11):4293–303.CrossRef Robinson C, Estrada A, Zaheer A, Singh VK, Wolfgang CL, Goggins MG, Hruban RH, Wood LD, Noe M, Montgomery EA, Guthrie LC, Lennon AM, Boyce AM, Collins MT. Clinical and radiographic gastrointestinal abnormalities in McCune-Albright syndrome. J Clin Endocrinol Metab. 2018;103(11):4293–303.CrossRef
21.
go back to reference Majoor BC, Boyce AM, Bovee JV, Smit VT, Collins MT, Cleton-Jansen AM, Dekkers OM, Hamdy NA, Dijkstra PS, Appelman-Dijkstra NM. Increased risk of breast cancer at a young age in women with fibrous dysplasia. J Bone Miner Res. 2018;33(1):84–90.CrossRef Majoor BC, Boyce AM, Bovee JV, Smit VT, Collins MT, Cleton-Jansen AM, Dekkers OM, Hamdy NA, Dijkstra PS, Appelman-Dijkstra NM. Increased risk of breast cancer at a young age in women with fibrous dysplasia. J Bone Miner Res. 2018;33(1):84–90.CrossRef
22.
go back to reference Florenzano P, Pan KS, Brown SM, Paul SM, Kushner H, Guthrie LC, de Castro LF, Collins MT, Boyce AM. Age-related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone. J Bone Miner Res. 2019;34(4):653–60.CrossRef Florenzano P, Pan KS, Brown SM, Paul SM, Kushner H, Guthrie LC, de Castro LF, Collins MT, Boyce AM. Age-related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone. J Bone Miner Res. 2019;34(4):653–60.CrossRef
23.
go back to reference Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus. 2010;28(4):E4.CrossRef Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus. 2010;28(4):E4.CrossRef
24.
go back to reference Jensterle M, Jazbinsek S, Bosnjak R, Popovic M, Zaletel LZ, Vesnaver TV, Kotnik BF, Kotnik P. Advances in the management of craniopharyngioma in children and adults. Radiol Oncol. 2019;53(4):388–96.CrossRef Jensterle M, Jazbinsek S, Bosnjak R, Popovic M, Zaletel LZ, Vesnaver TV, Kotnik BF, Kotnik P. Advances in the management of craniopharyngioma in children and adults. Radiol Oncol. 2019;53(4):388–96.CrossRef
25.
go back to reference Lee JS, FitzGibbon EJ, Chen YR, Kim HJ, Lustig LR, Akintoye SO, Collins MT, Kaban LB. Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis. 2012;7(Suppl 1):S2.CrossRef Lee JS, FitzGibbon EJ, Chen YR, Kim HJ, Lustig LR, Akintoye SO, Collins MT, Kaban LB. Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis. 2012;7(Suppl 1):S2.CrossRef
26.
go back to reference Li Z, Wang Z, Qian H. Malignant transformation of craniofacial fibrous dysplasia: a systematic review of overall survival. Neurosurg Rev. 2020;43(3):911–21.CrossRef Li Z, Wang Z, Qian H. Malignant transformation of craniofacial fibrous dysplasia: a systematic review of overall survival. Neurosurg Rev. 2020;43(3):911–21.CrossRef
Metadata
Title
Coexistence of craniopharyngioma and cranial fibrous dysplasia: a case series of clinicopathological study
Authors
Yang-Hua Fan
Zhi Li
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2022
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-022-02281-1

Other articles of this Issue 1/2022

Orphanet Journal of Rare Diseases 1/2022 Go to the issue